Stock of the Day for June 12, 2025

Stryker Stock Report

Stryker
SYK 90-day performance NYSE:SYK Stryker
Current Price
$383.32
-5.47 (-1.41%)
(As of 09/12/2025 03:59 PM ET)
30 Day Performance
1.26%
  
 
90 Day Performance
1.67%
  
 
1 Year Performance
3.55%
  
 
Market Capitalization
$146.55B
P/E Ratio
50.77
Dividend Yield
0.88%

About Stryker

Stryker Corporation is a leading global medical technology company specializing in innovative healthcare solutions. The company develops, manufactures and sells a diverse range of products and services in three primary segments: Orthopedics, MedSurg and Neurotechnology & Spine. Its Orthopedics division offers joint replacement implants, trauma products and reconstructive solutions, while its MedSurg segment provides surgical equipment, endoscopic and communications systems, patient handling and emergency medical equipment. The Neurotechnology & Spine group focuses on devices for the management of neurological and spinal disorders, including implants for spinal fusion, aneurysm treatment and brainshunt procedures.

Founded in 1941 by Dr. Homer Stryker in Kalamazoo, Michigan, the company grew from a small medical device shop into a Fortune 500 enterprise. Throughout its history, Stryker has expanded its product portfolio and geographic footprint through internal research and strategic acquisitions. Key acquisitions have included companies specializing in robotic surgery, wound care and advanced imaging, which have enhanced Stryker’s ability to offer end-to-end surgical solutions and minimally invasive treatment options.

Today, Stryker operates in more than 100 countries with manufacturing facilities, research and development centers and sales offices across North America, Europe, Asia Pacific, Latin America and the Middle East. The company invests heavily in R&D to advance technologies such as surgical robotics, digital operating room integration and personalized orthopedics. Its global supply chain and localized customer support help ensure timely product delivery and training for healthcare professionals.

Under the leadership of President and Chief Executive Officer Kevin A. Lobo, who has guided the company since 2012, Stryker emphasizes a culture of integrity, innovation and customer focus. The executive team maintains a commitment to quality, compliance and continuous improvement, while fostering collaboration with clinicians, researchers and industry partners to address evolving patient needs and drive long-term growth.

SYK Company Calendar

JUN. 30, 2025
Ex-Dividend for 7/31 Dividend
JUL. 31, 2025
Last Earnings
JUL. 31, 2025
Dividend Payable
SEP. 13, 2025
Today
SEP. 30, 2025
Ex-Dividend for 10/31 Dividend
OCT. 31, 2025
Dividend Payable
NOV. 4, 2025
Next Earnings (Estimated)
DEC. 31, 2025
Fiscal Year End

Recent Stryker News

Stryker Corporation $SYK Shares Acquired by Integrity Alliance LLC.
Stryker Corporation $SYK Shares Sold by Plato Investment Management Ltd
SCS Capital Management LLC Makes New Investment in Stryker Corporation $SYK
Stryker Corporation $SYK Stock Position Decreased by Fred Alger Management LLC
American Trust Decreases Stock Position in Stryker Corporation $SYK
MBB Public Markets I LLC Invests $334,000 in Stryker Corporation $SYK
This report was written by MarketBeat.com on June 12, 2025 and updated on September 13, 2025. This report first appeared on MarketBeat.com.